Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 4 of 5 found articles
 
 
  Taurine – a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by ^{1}H NMR spectroscopy
 
 
Title: Taurine – a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by ^{1}H NMR spectroscopy
Author: Srivastava, Shatakshi
Roy, Raja
Singh, Sudhir
Kumar, Praveen
Dalela, Diwakar
Sankhwar, Satya N.
Goel, Apul
Sonkar, Abhinav A.
Appeared in: Disease markers. Section A, Cancer biomarkers
Paging: Volume 6 (2010) nr. 1 pages 11-20
Year: 2010-02-17
Contents: Urinary bladder cancer is a major epidemiological problem that continues to grow each year. It opens avenues for investigative research for the identification of new disease markers and diagnostic techniques. In this pilot study, utility of non-invasive ^{1}H NMR spectroscopy has been evaluated for probing the metabolic perturbations occurring in non-muscle invasive urinary bladder cancer. ^{1}H NMR spectra of urine of bladder cancer patients and controls (healthy and urinary tract infection/bladder stone) (n=103) were acquired at 400MHz. The non-overlapping resonances of citrate, dimethylamine, phenylalanine, taurine and hippurate were first identified and then quantitated by ^{1}H NMR spectra, with respect to an external reference sodium-3-trimethylsilylpropionate (TSP). The concentrations of these metabolites were then statistically analyzed. The cancer patients showed significant (p< 0.05) variations in concentration of hippurate and citrate as compared with healthy controls and benign controls. The significant elevation in concentration of taurine was observed in urine of bladder cancer patients, which was below the sensitivity limit of 400MHz in control cases. However, stages Ta, T1 and carcinoma in situ (CIS) cannot be differentiated on the basis of altered metabolite indices but their composition may reflect the biochemical alterations in metabolism of cancer cells.
Publisher: IOS Press
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 4 of 5 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands